The George Washington University School of Medicine and Health SciencesWashington DC, District of Columbia, United States
0559: Impact of Secukinumab on Cardiovascular Disease in Patients with Psoriasis, PsA, and Axial Spondyloarthritis: A Systematic Review of Existing Evidence
Sunday, October 26, 202510:30 AM - 12:30 PM Central Time
Disclosure information not submitted.